Protagonist Therapeutics: H.C. Wainwright raises target price to $221 from $170
PTGX•H.C. Wainwright raised its target price for Protagonist Therapeutics to $221 from $170.
Related News
Hawkeye Digital partners with Securitize to tokenize common stock on Ethereum
HWKE•
MSG Rangers reports fiscal 2027 first-quarter results
MSGR•
Caterpillar Construction Industries President Rod Shurman joins Bernstein fireside chat
CAT•
U.S. added 165,000 jobs in October as unemployment rate fell to 4.1%
SPY•
TSMC reportedly weighs making advanced memory chips to capture more AI spending
TSM•